Literature DB >> 22571487

Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome.

Davide Rossi, Silvia Rasi, Valeria Spina, Marco Fangazio, Sara Monti, Mariangela Greco, Carmela Ciardullo, Rosella Famà, Stefania Cresta, Alessio Bruscaggin, Luca Laurenti, Maurizio Martini, Pellegrino Musto, Francesco Forconi, Roberto Marasca, Luigi M Larocca, Robin Foà, Gianluca Gaidano.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22571487     DOI： 10.1111/j.1365-2141.2012.09155.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  27 in total

1.  Haematological cancer: Richter's transformation in CLL-a distinct lymphoma.

Authors:  Preetesh Jain; Ken H Young
Journal:  Nat Rev Clin Oncol       Date:  2013-11-26       Impact factor: 66.675

2.  How we treat Richter syndrome.

Authors:  Sameer A Parikh; Neil E Kay; Tait D Shanafelt
Journal:  Blood       Date:  2014-01-13       Impact factor: 22.113

Review 3.  Splicing factor mutations in myelodysplasia.

Authors:  Seishi Ogawa
Journal:  Int J Hematol       Date:  2012-10-05       Impact factor: 2.490

Review 4.  Molecular pathogenesis of chronic lymphocytic leukemia.

Authors:  Gianluca Gaidano; Robin Foà; Riccardo Dalla-Favera
Journal:  J Clin Invest       Date:  2012-10-01       Impact factor: 14.808

Review 5.  The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment.

Authors:  Gianluca Gaidano; Davide Rossi
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2017-12-08

Review 6.  Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents.

Authors:  Joseph Maly; James S Blachly
Journal:  Curr Hematol Malig Rep       Date:  2016-02       Impact factor: 3.952

7.  Chronic lymphocytic leukemia/small lymphocytic lymphoma, version 1.2015.

Authors:  Andrew D Zelenetz; Leo I Gordon; William G Wierda; Jeremy S Abramson; Ranjana H Advani; C Babis Andreadis; Nancy Bartlett; John C Byrd; Myron S Czuczman; Luis E Fayad; Richard I Fisher; Martha J Glenn; Thomas M Habermann; Nancy Lee Harris; Richard T Hoppe; Steven M Horwitz; Christopher R Kelsey; Youn H Kim; Susan Krivacic; Ann S LaCasce; Auayporn Nademanee; Pierluigi Porcu; Oliver Press; Rachel Rabinovitch; Nishitha Reddy; Erin Reid; Ayman A Saad; Lubomir Sokol; Lode J Swinnen; Christina Tsien; Julie M Vose; Lynn Wilson; Joachim Yahalom; Nadeem Zafar; Mary Dwyer; Hema Sundar
Journal:  J Natl Compr Canc Netw       Date:  2015-03       Impact factor: 11.908

Review 8.  Risk factors for Richter syndrome in chronic lymphocytic leukemia.

Authors:  Sameer A Parikh; Tait D Shanafelt
Journal:  Curr Hematol Malig Rep       Date:  2014-09       Impact factor: 3.952

Review 9.  Clinical implications of the molecular genetics of chronic lymphocytic leukemia.

Authors:  Robin Foà; Ilaria Del Giudice; Anna Guarini; Davide Rossi; Gianluca Gaidano
Journal:  Haematologica       Date:  2013-05       Impact factor: 9.941

10.  Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): a cohort study of newly diagnosed patients.

Authors:  Sameer A Parikh; Kari G Rabe; Timothy G Call; Clive S Zent; Thomas M Habermann; Wei Ding; Jose F Leis; Susan M Schwager; Curtis A Hanson; William R Macon; Neil E Kay; Susan L Slager; Tait D Shanafelt
Journal:  Br J Haematol       Date:  2013-07-11       Impact factor: 6.998
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.